BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 17893375)

  • 1. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
    Catena C; Colussi GL; Marzano L; Sechi LA
    Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
    Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will the lessons from primary aldosteronism change the treatment of hypertension and left ventricular hypertrophy?
    Auchus RJ; Drazner MH
    Hypertension; 2007 Nov; 50(5):837-9. PubMed ID: 17909118
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
    Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
    J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
    Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J
    J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term renal outcomes in patients with primary aldosteronism.
    Sechi LA; Novello M; Lapenna R; Baroselli S; Nadalini E; Colussi GL; Catena C
    JAMA; 2006 Jun; 295(22):2638-45. PubMed ID: 16772627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study.
    Catena C; Colussi G; Novello M; Verheyen ND; Bertin N; Pilz S; Tomaschitz A; Sechi LA
    Hypertension; 2016 Jul; 68(1):204-12. PubMed ID: 27245179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
    Chang YY; Liao CW; Tsai CH; Chen CW; Pan CT; Chen ZW; Chen YL; Lin LC; Chang YR; Wu VC; Wu KD; Hung CS; Lin YH; ;
    J Am Heart Assoc; 2019 Nov; 8(22):e013263. PubMed ID: 31718437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
    Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
    J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Left ventricular myocardial structure and function in patients with primary aldosteronism].
    Arabidze GG; Chikhladze NM; Sergakova LM; Iarovaia EB
    Ter Arkh; 1999; 71(9):13-9. PubMed ID: 10553618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
    Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
    J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.